- Report
- August 2023
- 150 Pages
North America
From €4574EUR$4,750USD£3,934GBP
- Report
- August 2023
- 300 Pages
Middle East, Africa
From €4719EUR$4,900USD£4,058GBP
- Report
- August 2023
- 300 Pages
Latin America
From €4719EUR$4,900USD£4,058GBP
- Report
- August 2023
- 300 Pages
Asia Pacific
From €4719EUR$4,900USD£4,058GBP
- Report
- August 2023
- 300 Pages
Europe
From €4719EUR$4,900USD£4,058GBP
- Report
- February 2021
- 500 Pages
United States
From €2311EUR$2,400USD£1,988GBP
- Report
- December 2022
- 66 Pages
Global
From €3371EUR$3,500USD£2,899GBP
- Report
- March 2022
- 140 Pages
Global
From €1916EUR$1,990USD£1,648GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3467EUR$3,600USD£2,982GBP
- Report
- February 2023
- 130 Pages
France
From €2398EUR$2,490USD£2,062GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4574EUR$4,750USD£3,934GBP
- Report
- February 2024
- 70 Pages
South Africa
From €4574EUR$4,750USD£3,934GBP
- Report
- February 2024
- 70 Pages
Indonesia
From €4574EUR$4,750USD£3,934GBP
- Report
- February 2024
- 70 Pages
Philippines
From €4574EUR$4,750USD£3,934GBP
- Report
- February 2024
- 70 Pages
India
From €4574EUR$4,750USD£3,934GBP
- Report
- February 2024
- 70 Pages
Japan
From €4574EUR$4,750USD£3,934GBP
- Report
- February 2024
- 70 Pages
Italy
From €4574EUR$4,750USD£3,934GBP
- Report
- February 2024
- 70 Pages
India
From €4574EUR$4,750USD£3,934GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4574EUR$4,750USD£3,934GBP
- Report
- February 2024
- 70 Pages
Germany
From €4574EUR$4,750USD£3,934GBP
The Sodium Dependent Glucose Co Transporter 2 (SGLT2) market is a subset of the Endocrine and Metabolic Disorders Drugs market. SGLT2 inhibitors are a class of drugs used to treat type 2 diabetes, a chronic condition in which the body does not produce enough insulin or is unable to use insulin effectively. These drugs work by blocking the reabsorption of glucose in the kidneys, allowing it to be excreted in the urine. This helps to reduce blood glucose levels and improve glycemic control.
The SGLT2 market is highly competitive, with several major pharmaceutical companies offering products. These include AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen Pharmaceuticals, Merck, Novo Nordisk, and Sanofi. Each company offers a range of products, including both branded and generic versions. Show Less Read more